In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Analysis of Deaths Due to Gender-Based Violence: An Autopsy-based Cross-sectional Study from Mumbai
Basic Drug Use Epidemiology Guide
A Snapshot of Medication Diversion Among 6 Jails Expanding Access to Agonist Medications…
E-NNOVATE- Electronic innovations in cancer registration
Pennsylvania Opioid Settlement Funds
Wisconsin Opioid Settlement Funds
North Carolina Opioid Settlement Funds
New Mexico Opioid Settlement Funds
New Jersey Opioid Settlement Funds
Michigan Opioid Settlement Funds